A study using Botulinum Toxin Type A in adolescents with axillary hyperhidrosis.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
144
100 U up to 6 times during the study depending on the response to treatment
Unnamed facility
Portland, Oregon, United States
Unnamed facility
Vancouver, British Columbia, Canada
Subject's assessment of the severity of hyperhidrosis using the HDS Scale
Time frame: Monthly
Measurement of axillary sweat production
Time frame: Week 4, Week 8 and any re-injection visit
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.